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Abstract
Background: Perturbation of commensal intestinal microbiota has been associated with several autoimmune
diseases. Mice deficient in interleukin-1 receptor antagonist (Il1rn−/− mice) spontaneously develop autoimmune
arthritis and are susceptible to other autoimmune diseases such as psoriasis, diabetes, and encephalomyelitis;
however, the mechanisms of increased susceptibility to these autoimmune phenotypes are poorly understood. We
investigated the role of interleukin-1 receptor antagonist (IL-1Ra) in regulation of commensal intestinal microbiota,
and assessed the involvement of microbiota subsets and innate and adaptive mucosal immune responses that
underlie the development of spontaneous arthritis in Il1rn−/− mice.
Results: Using high-throughput 16S rRNA gene sequencing, we show that IL-1Ra critically maintains the diversity
and regulates the composition of intestinal microbiota in mice. IL-1Ra deficiency reduced the intestinal microbial
diversity and richness, and caused specific taxonomic alterations characterized by overrepresented Helicobacter and
underrepresented Ruminococcus and Prevotella. Notably, the aberrant intestinal microbiota in IL1rn−/− mice
specifically potentiated IL-17 production by intestinal lamina propria (LP) lymphocytes and skewed the LP T cell
balance in favor of T helper 17 (Th17) cells, an effect transferable to WT mice by fecal microbiota. Importantly, LP
Th17 cell expansion and the development of spontaneous autoimmune arthritis in IL1rn−/− mice were attenuated
under germ-free condition. Selective antibiotic treatment revealed that tobramycin-induced alterations of
commensal intestinal microbiota, i.e., reduced Helicobacter, Flexispira, Clostridium, and Dehalobacterium, suppressed
arthritis in IL1rn−/− mice. The arthritis phenotype in IL1rn−/− mice was previously shown to depend on Toll-like
receptor 4 (TLR4). Using the ablation of both IL-1Ra and TLR4, we here show that the aberrations in the IL1rn−/−
microbiota are partly TLR4-dependent. We further identify a role for TLR4 activation in the intestinal lamina propria
production of IL-17 and cytokines involved in Th17 differentiation preceding the onset of arthritis.
Conclusions: These findings identify a critical role for IL1Ra in maintaining the natural diversity and composition of
intestinal microbiota, and suggest a role for TLR4 in mucosal Th17 cell induction associated with the development
of autoimmune disease in mice.
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Background
Interleukin-1 (IL-1) plays a central role in inflammation
and immunity [1]. Activation of IL-1 receptor is physio-
logically controlled by its structural homologue and nat-
ural inhibitor, the IL-1 receptor antagonist (IL-1Ra),
encoded by the IL1rn gene [2]. IL1rn knockout (IL1rn
−/−) mice are susceptible to a variety of autoimmune dis-
eases including arthritis, psoriasis, diabetes, and enceph-
alomyelitis [3–7]. This indicates a critical role for IL-1Ra
in protection against autoimmunity; however, the mech-
anisms are poorly understood.
We questioned the role of IL-1Ra in regulation of the in-
testinal microbiota and the involvement of mucosal im-
mune response as an underlying mechanism for the
spontaneous autoimmune arthritis in IL1rn−/− mice, which
is dependent on T cells and IL-17 [4, 8]. Several studies
have associated commensal microbiota with autoimmune
disease in mouse models of rheumatoid arthritis (RA), dia-
betes, and multiple sclerosis [9–13]. Importantly, the diver-
sity and the composition of commensal intestinal
microbiota are altered in patients with psoriatic and RA
compared with healthy individuals [14–18]. One of the
most prominent effects of microbiota is to define the
balance between the proinflammatory CD4+ T helper
1 (Th1) and Th17 cells and protective regulatory T
(Treg) cells, both at mucosal surfaces and systemic-
ally [19–21]. In this context, specific subsets of in-
testinal microbiota, such as the vancomycin-sensitive
segmented filamentous bacteria (SFB), robustly in-
duce differentiation of Th17 cells in small intestine
LP (SI-LP) [22, 23]. Th17 cells are considered to
play a pathogenic role in a subset of patients with
RA by producing proinflammatory mediators, such
as IL-17, and inducing osteoclastogenesis [24–28].
Interestingly, SFB colonization has been shown to
exacerbate arthritis in K/BxN mice, an autoimmune
model of arthritis arising from T cell auto-reactivity
to the glycolytic enzyme glucose-6-phosphate isom-
erase [13, 29]. However, given that SFB were not
found in human adults [30, 31], it is important to
investigate the involvement of other indigenous
microbiota in arthritis.
We previously described that arthritis in IL1rn−/− mice is
diminished under germ-free (GF) condition [12]. We also
showed that IL1rn−/− arthritis is dependent on the activa-
tion of Toll-like receptor 4 (TLR4), which affected systemic
Th17 cell differentiation [12]. Here, we characterized the
intestinal microbiota present in autoimmune-prone IL1rn
−/− mice to clarify the nature of the microbiota that trigger
arthritis and the underlying mucosal immune pathways.
We also examined the role of TLR4 in the intestinal muco-
sal immune responses associated with arthritis.
Using high-throughput 16S ribosomal RNA (rRNA)
gene sequencing of fecal microbiota, we demonstrate a
critical role for IL-1Ra in maintaining the natural diver-
sity and composition of commensal intestinal micro-
biota. We show that the aberrant IL1rn−/− microbiota
increases intestinal Th17 cell differentiation, a phenotype
that is transferable to wild-type (WT) mice by the
microbiota. We also provide evidence that tobramycin-
sensitive indigenous commensal intestinal bacteria con-
tribute to arthritis in IL1rn−/− mice and identify a signifi-
cant role for TLR4 in mucosal induction of IL-1β and
IL-17 prior to the onset of arthritis.
Results
IL-1Ra maintains the biodiversity and richness of
commensal intestinal microbiota
To identify intestinal microbiota associated with arth-
ritis, we sequenced fecal bacterial 16S rRNA genes of
IL1rn−/− and age- and gender-matched WT control mice.
Fecal microbiota were analyzed as an unselected repre-
sentation of the overall microbial communities in the in-
testines. Considering differential roles of TLR2 and
TLR4 in IL1rn−/− arthritis [12], we sequenced samples of
IL1rn−/− Tlr2−/− and IL1rn−/− Tlr4−/− mice in parallel.
The average sequencing depth and total numbers of
reads and operational taxonomic units (OTU) per experi-
mental group as well as the hierarchical weighed UniFrac
cluster analysis at the genus level are shown in Additional
file 1: Table S1 and Additional file 1: Figure S1.
Principal coordinates analysis (PCoA) based on an
unweighted UniFrac analysis of intestinal microbiota
showed that IL1rn−/− microbiota is profoundly differ-
ent from the WT microbiota (Fig. 1a). WT and Il1rn
−/− mice formed clear, separate clusters regardless of
the cage or litter of origin (Fig. 1a). Strikingly, mi-
crobial composition of IL1rn−/− and IL1rn−/− Tlr2−/−
mice were indistinguishable, while IL1rn−/− Tlr4−/−
mice formed another distinct cluster (Fig. 1a). To as-
sess the effects of familial transmission and lineage
origin versus the effect of the genotype (WT or
IL1rn−/−), we compared the UniFrac distances within
a litter with UniFrac distances across litters of the
same genotype as well as the opposite genotype,
similar to the study by Ubeda et al. This analysis
showed that the effect of the lineage origin and litter
was limited in our experimental setting, because, as long
as the genotype remained the same, the UniFrac distances
across different litters were very similar to the UniFrac
distances within the litters (Additional file 1: Figure S2A).
This was true for both WT and Il1rn−/− groups. Import-
antly, the UniFrac distances were significantly higher
when mice from different genotypes were compared, indi-
cating a higher level of dissimilarity (Additional file 1:
Figure S2B). Therefore, the effect of the genotype (Il1rn-
deficiency) on the overall microbiota composition was
significantly higher than any litter and cage effect. In
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addition, IL1rn−/− and IL1rn−/− Tlr2−/− mice showed
significantly reduced number of OTUs and loss of
microbial diversity based on the Shannon index, the
rarefaction curves of phylogenetic distance (PD) whole tree,
and the diversity index bootstrapped for the number of
retrieved sequences (Fig. 1b–e). IL-1Ra deficiency also re-
sulted in loss of species richness estimated by Chao index
(Fig. 1f). These effects were fully or partially restored in
IL1rn−/− Tlr4−/− mice (Fig. 1b–f ). Altogether, these data
strongly suggest that IL-1Ra plays a critical role in main-
taining the intestinal microbial diversity, and that the loss
of diversity in IL1rn−/− mice partially depends on TLR4.
Specific taxonomic alterations characterize the
dysregulated microbiota of autoimmune-prone IL1rn−/−
mice
The phylogenetic tree in Fig. 2 summarizes the ob-
served alterations in relative abundances of microbial
taxa. Compared with WT microbiota, we found a
highly significant overrepresentation of the genus
Helicobacter (P = 0.004, Bonferroni corrected), and a
significant underrepresentation of the genus Prevo-
tella (P = 0.008, Bonferroni corrected) (Fig. 2 and
Additional file 1: Table S2). In addition, IL1rn−/− in-
testinal microbial composition was characterized by
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Fig. 1 IL-1Ra deficiency skews intestinal microbial composition and reduces its diversity in a TLR4-dependent manner. a Principal coordinates analysis
(PCoA) based on an unweighted UniFrac analysis of the intestinal microbial composition where samples of mice from different cages and litters are
highlighted with different colors. The position and distance of data points indicates the degree of similarity in terms of both presence and relative
abundance of bacterial taxonomies. b Number of observed operational taxonomic units (OTUs). c Shannon index of microbial diversity. d Alpha diversity
rarefaction curves of phylogenetic distance (PD) whole tree. e PD whole tree, bootstrapped for 2000 reads per sample, averaged of four trials. f Chao index
are shown. Data (mean + SEM) represent 16S rRNA gene 454-pyrosequencing analysis of intestinal microbiota of WT (n= 9), IL1rn−/− (n= 15), IL1rn−/− Tlr2−/−
(n= 8), and IL1rn−/− Tlr4−/− (n= 8) mice. n.s. not significant,*P≤ 0.05 and ***P≤ 0.001, by Mann-Whitney U test. See also Additional file 1: Figure S1 and
Additional file 1: Table S1
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expansion of Butyricimonas, Rikenella, and Strepto-
coccus by 10, 3.7, and 2.4 folds (P = 0.0048, P =
0.0022, and P = 0.0032, respectively, Bonferroni un-
corrected), along with a decrease in Parasutterella,
Xylanibacter, Ruminococcus, and Barnesiella by 10,
6.9, 2.7, and 1.4 folds (P = 0.040, P = 0.0004, P =
0.0099, and P = 0.0005, respectively, Bonferroni un-
corrected), respectively (Fig. 2 and Additional file 1:
Table S2). Notably, we were unable to identify any
OTUs in our dataset that could be classified as SFB
(family Clostridiaceae, genus Candidatus Arthromi-
tus). Moreover, none of the 27 present OTUs
assigned to the family Clostridiaceae aligned with
the known SFB 16S gene sequences in The Riboso-
mal Database Project [30]. However, SFB were de-
tectable by qPCR in fecal samples of all WT mice
and most of the Il1rn−/− mice (Additional file 1:
Table S3). Although WT mice tended to have slightly
more SFB, the level of SFB colonization was not signifi-
cantly different between the groups (Additional file 1:
Table S3).
Altogether, these data suggest that multiple yet spe-
cific microbial taxa are regulated by the physiologic
expression of IL-1Ra. Therefore, a complex set of ab-
errant microbiota may affect the (mucosal) immune
response and contribute to the autoimmune disease
in IL1rn−/− mice.
IL1rn−/− intestinal microbiota potentiate IL-17 production
by intestinal lamina propria lymphocytes
To assess the effect of IL-1Ra deficiency on the mucosal
T cell response, we cultured enzymatically isolated lam-
ina propria lymphocytes (LPL) ex vivo in the presence of
PMA and ionomycin. The production of the Th1 signa-
ture cytokine IFNγ was low and not altered by the IL-
1Ra deficiency (Fig. 3a, gating strategy shown in Add-
itional file 1: Figure S3); however, we observed a marked
increase in the production of IL-17 by IL1rn−/− LPLs
compared with WT LPLs (Fig. 3b). Flow cytometry ana-
lysis of lamina propria cells of WT and IL1rn−/− mice
verified a significant, clear increase of IL-17-producing
TCRβ+ CD4+ cells in IL1rn−/− mice, while TCRβ− cells
Fig. 2 IL-1 receptor antagonist controls relative abundance of specific intestinal microbial taxa. Phylogenetic tree created by Cytoscape software
showing specific changes in intestinal microbial community at different taxonomic levels induced by IL-1Ra deficiency. Nodes represent taxa, and
the size of each node represents its relative abundance. The color red indicates a decrease and blue represents an increase of relative abundance
in IL1rn−/− compared with WT mice. The thickness of the green border indicates the degree of the statistical significance by Mann-Whitney U test.
See also Additional file 1: Table S2
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in LP produced similar amounts of IL-17 in WT and
IL1rn−/− mice (Additional file 1: Figure S4). This sug-
gests that Th17 cells, not γδ T cells, are the source of in-
creased IL-17 production in LP of IL1rn−/− mice.
Production of IL-4, IL-6, and TNFα was not affected
(Fig. 3c and data not shown). Interestingly, the produc-
tion of IL-17 but not IFNγ by lymphocytes in joint-
draining lymph nodes (dLN) was significantly increased
in IL1rn−/− mice compared with WT mice (Fig. 3d, e).
This was paralleled by a concomitant decrease in the
production of the Th2-related cytokine IL-4 in IL1rn−/−
mice (Fig. 3f ).
To identify a potential causative relationship between
the aberrant microbiota and enhanced mucosal IL-17
production, we transferred IL1rn−/− microbiota to WT
mice by oral gavage followed by immediate co-housing
of the two mouse strains for up to 6 weeks. Transfer of
IL1rn−/− microbiota clearly potentiated IL-17 production
by SI-LP T cells in WT recipients as early as 10 days
post fecal transfer and co-housing, without affecting
IFNγ and IL-4 (Fig. 3g–i). This indicated that IL1rn−/−
intestinal microbiota causes a shift in the LP T cell bal-
ance in favor of Th17 cells. However, this was not
sufficient for the development of arthritis in WT
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Fig. 3 Il1rn−/− intestinal microbiota potentiate IL-17 production in intestinal lamina propria and joint-draining lymph nodes. a–i Production of
prototypic Th1, Th17, and Th2 cell cytokines (IFNγ, IL-17A, and IL-4, respectively) by SI-LP (a–c and g–i) and draining lymph node (dLN) lympho-
cytes (d–f). Cells were isolated from WT and IL1rn−/− mice (a–f) or WT mice transplanted with IL1rn−/− feces and co-housed with IL1rn−/− mice for
10 days (g–i). Cells were stimulated ex vivo with PMA and ionomycin in duplicates for 5 h, and cytokines were measured by Luminex assay. Data
represent mean + SEM of a representative experiment with n = 5 (a–c) and n = 3 (d–i) mice per group, each stimulated in duplicate. n.s. not sig-
nificant, *P≤ 0.05 and ***P ≤ 0.001, by Mann-Whitney U test. See also Additional file 1: Figure S2
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animals during the 6-week follow-up period. This
suggests that additional (genetic) susceptibility of the
host, as in IL1rn−/− mice, is required for the develop-
ment of arthritis. Furthermore, co-housing with WT
mice did not affect the development of arthritis in
IL1rn−/− mice (not shown).
Potentiated Th17 response and spontaneous arthritis in
IL1rn−/− mice highly depend on the presence of
commensal microbiota
To determine whether the increase in intestinal Th17
cells and spontaneous arthritis in IL1rn−/− mice depends
on commensal microbiota, we established GF IL1rn−/−
mice. Flow cytometry analysis of LPLs showed that
germ-free condition had no significant effect on the per-
centage of Th1 cells while reducing the numbers of Th1
cells in SI-LP (Fig. 4a, b). In contrast, both the percent-
age and the number of SI-LP Th17 cells were substan-
tially reduced in GF compared with conventional (CV)
mice (Fig. 4c, d). This strongly suggests that the skewed
intestinal T cell balance in IL1rn−/− mice is largely
microbiota dependent.
In agreement with IL-17-dependence of IL1rn−/− arth-
ritis [4, 8] and in line with our previous observations
[12], GF IL1rn−/− mice showed a clear sustained protec-
tion from arthritis with on average 3 weeks delay in dis-
ease onset (Fig. 4e). In addition, transfer of conventional
IL1rn−/− microbiota to GF IL1rn−/− mice re-induced
arthritis and resulted in a severe disease comparable to
that in conventional IL1rn−/− mice (Additional file 1:
Figure S5). Therefore, IL1rn−/− commensal microbiota,
although not sufficient to induce arthritis in a WT host,
are critical for the full development of arthritis in IL1rn
−/− mice. Consistently, we also observed a robust reduc-
tion of IL-17, but not IFNγ, production in the spleen
and most notably in the joint-adjacent lymph nodes of
GF mice (Fig. 4f, g). These effects were accompanied by
a significant reciprocal increase in Th2-related cytokines
IL-4 and IL-10 as well as IL-2 in the spleens of GF mice
(Fig. 4h and Additional file 1: Figure S6). These data
support modulation of extra-intestinal immune response
by intestinal microbiota during arthritis.
Tobramycin-induced alteration of intestinal microbiota
suppresses arthritis in IL1rn−/− mice
The lack of microbiota in GF mice is not limited to the
intestines. To determine whether intestinal microbiota
serve as a relevant trigger for arthritis, we first depleted
intestinal microbiota in conventionally housed mice
using a cocktail of metronidazole, neomycin, and ampi-
cillin. Treatment of 5-week-old IL1rn−/− mice for only
1 week suppressed arthritis over a sustained period, i.e.,
6 weeks after ceasing antibiotics (Fig. 5a). This indicated
that abrogation of arthritis in GF mice (Fig. 4c) is not
due to an immature immune system and, more import-
antly, can be reproduced by the sole eradication of intes-
tinal microbiota. Interestingly, colonization of the
antibiotic-treated mice with SFB as model organisms in-
ducing SI-LP Th17 cells was sufficient to fully restore
arthritis (Fig. 5a).
To determine which subset of IL1rn−/− microbiota
triggers arthritis, we first compared the effects of treat-
ment with ampicillin, broadly targeting aerobic bacteria,
and metronidazole, broadly targeting anaerobic bacteria.
To our surprise, only metronidazole showed efficacy in
reducing arthritis severity (Fig. 5b). This suggests in-
volvement of anaerobic bacteria in the progression of
arthritis. We next compared the effects of more selective
antibiotics tobramycin and vancomycin, the latter of
which has been reported to eradicate SFB and inhibit
SFB-induced lamina propria Th17 cells and arthritis
[13, 22, 32]. These experiments revealed that although
SFB were able to exacerbate arthritis in IL1rn−/− mice
(Fig. 5a), only tobramycin but not vancomycin signifi-
cantly diminished arthritis (Fig. 5c). To understand
the changes in the microbiota induced by tobramycin
treatment, we compared 16S rRNA gene sequences of
fecal microbiota at the end-point of tobramycin treat-
ment with the baseline microbiota. Among taxa with
>0.1% relative abundance, tobramycin treatment re-
sulted in a near-complete elimination of the genera
Helicobacter and Flexispira (both belonging to the
family Helicobacteraceae). In addition, a strong and
highly significant reduction in the genera Clostridium
and Dehalobacterium was observed (Additional file 1:
Figure S7 and Table S4). Other changes in the microbiota
did not reach the statistical significance after Bonferroni
correction for multiple testing. Therefore, tobramycin-
induced alterations in these indigenous IL1rn−/− micro-
biota taxa resulted in suppression of arthritis. This was
confirmed by histological examination of arthritic joints
which showed a significant reduction of synovial inflam-
mation as well as cartilage destruction and a non-
significant reduction in bone erosion upon treatment with
tobramycin (Fig. 5d, e).
Aberrations of the intestinal microbiota and LP IL-17
production in IL1rn−/− mice partly depend on TLR4
TLR4 plays a major role in recognition of Gram-negative
bacteria [33]. We previously showed that IL1rn−/− Tlr4−/−
mice have a marked and sustained reduction of arthritis
[12]. Therefore, we assessed whether TLR4 plays a role in
alterations of the intestinal microbiota and the induction
of LP Th17 cells. A detailed analysis of the intestinal
microbiota showed that in addition to the TLR4-
dependent loss of microbial diversity in IL-1Ra-deficient
mice (Fig. 1b–f ), alterations in Ruminococcus, Streptococ-
cus, and Xylanibacter were partially dependent on TLR4
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and were restored in IL1rn−/− Tlr4−/− mice (Fig. 6a).
Abundance of Prevotella was also restored to a statistically
significant, yet minor extent (Fig. 6b). In total, 11 out of
44 taxa significantly altered in IL1rn−/− mice were
normalized toward the WT levels in IL1rn−/− Tlr4−/−
mice (Additional file 1: Table S2).
We next examined the role of TLR4 in the mucosal T
cell response in IL1rn−/− mice. Th17 cells require trans-
forming growth factor-β and IL-6, plus IL-1β in mouse,
for initial differentiation, and IL-23 for their functional
maturation and pathogenic function [24, 34]. To deter-
mine the role of TLR4 in response to IL1rn−/− intestinal
microbial antigens, we cultured SI-LP mononuclear cells
from IL1rn−/− and IL1rn−/− Tlr4−/− mice ex vivo with
autoclaved IL1rn−/− intestinal microbiota. SI-LP mono-
nuclear cells from IL1rn−/− Tlr4−/− mice produced sig-
nificantly less IL-1β (Fig. 7a, P = 0.0042). Furthermore,
the induction of IL-23 and IL-6 by IL1rn−/− fecal micro-
biota was partly TLR4-dependent (Fig. 7b, c, P = 0.0014
and P = 0.009, respectively). Reduced cytokine produc-
tion in IL1rn−/− Tlr4−/− mice was not due to an altered
composition of mononuclear cells in the SI-LP, because
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Fig. 4 Commensal microbiota drive potentiated Th17 response and spontaneous arthritis in IL1rn−/− mice. a–d Frequency and numbers of IFNγ-
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bone erosion in control and tobramycin-treated IL1rn−/− mice. n= 9 per group. *P≤ 0.05, by Mann-Whitney U test
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CD11b−, and CD11b+ CD103− phagocytes were similar
between IL1rn−/− and IL1rn−/− Tlr4−/− mice (data not
shown). Importantly, stimulation of IL1rn−/− LP mono-
nuclear cells with IL1rn−/− and IL1rn−/− Tlr4−/− fecal
microbial antigens induced similar concentrations of
IL-1β, IL-23, and IL-6 (Additional file 1: Figure S8). This
suggests that the altered composition of microbiota in
IL1rn−/− Tlr4−/− mice as such is not responsible for the
lower production of these cytokines. These observations
imply a significant role for TLR4 in intestinal production
of the cytokines involved in LP Th17 differentiation in
IL1rn−/− mice.
When cultured ex vivo with PMA and ionomycin,
SI-LP cells from IL1rn−/− Tlr4−/− mice produced signifi-
cantly less IL-17 compared with cells from IL1rn−/− Tlr4
+/+ mice before the onset of arthritis (P = 0.0028; Fig. 7d).
The amount of IFNγ produced in this culture was about
50 folds lower than IL-17 and was significantly reduced
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in IL1rn−/− Tlr4−/− mice as well (Fig. 7e). However, IL-4
levels remained unaffected (Fig. 7f ). LP T cells from
IL1rn−/− Tlr4−/− mice still produced significantly less
IL-17 and IFNγ when these mice were co-housed with
IL1rn−/− (Tlr4+/+) mice to transfer the microbiota
(Fig. 7g–i). Therefore, reduced LP IL-17 production in
IL1rn−/− Tlr4−/− mice is a result of the difference in host
TLR4 expression rather than altered microbiota in IL1rn
−/− Tlr4−/− versus IL1rn−/− mice. Stimulation of LP
mononuclear cells of these co-housed mice with fecal
microbial antigens confirmed that cells from IL1rn−/−
Tlr4−/− mice produce lower amounts of IL-1β, IL-23,
and IL-6 regardless of stimulation with IL1rn−/− or IL1rn
−/− Tlr4−/− microbiota (Additional file 1: Figure S9).
These data suggest that TLR4 activation contributes to
intestinal LP production of IFNγ and most notably
IL-17, and these effects precede the onset of arthritis.
Importantly, production of IL-17 but not IFNγ in
lymph nodes draining the inflamed joints was dimin-
ished in IL1rn−/− Tlr4−/− mice compared with IL1rn−/−
mice (Additional file 1: Figure S10). This is in agreement
with our previous study showing that TLR4 induces sys-
temic and local IL-17 production and promotes arthritis
in IL1rn−/− mice [12]. Together, these observations sug-
gest an essential role for TLR4 in the induction of intes-
tinal LP IL-17 production associated with extra-
intestinal IL-17 levels and the development of arthritis
in IL1rn−/− mice.
Discussion
The intestinal microbiome has emerged as a key deter-
minant of health and disease. Although advanced se-
quencing techniques have enabled microbiome profiling
in rheumatic patients, study of the underlying mucosal
responses and the functional impact on arthritis is lim-
ited in human subjects due to the requirement of inva-
sive techniques. The animal studies presented here
demonstrate aberrations in intestinal microbiota in mice
developing spontaneous autoimmune arthritis, introduce
commensal tobramycin-sensitive microbiota as potential
triggers for arthritis, and suggest a role for TLR4 activa-
tion in mucosal induction of inflammatory pathways in-
cluding Th17 induction associated with arthritis.
Our study identifies loss of microbial diversity and
specific taxonomic alterations in the microbiota of
autoimmune-prone IL1rn−/− mice. Importantly, loss of
intestinal microbial diversity and richness also coincides
with human autoimmune diseases such as diabetes and
rheumatoid and psoriatic arthritis [14, 16, 35]. Among
the microbiota increased in IL1rn−/− mice, Streptococcus
species are known inducers of chronic TLR-mediated
arthritis in animal models when injected intra-articularly
[36, 37]. Furthermore, a commensal Helicobacter (H.
hepaticus) has been shown to induce IL-23 and mediate
T cell-dependent gut inflammation in immunocom-
promised mice [38]. The decreased Barnesiella in IL1rn
−/− mice is consistent with a previous study associating
the abundance of Barnesiella with resistance to arthritis
in HLA-DRB1*0402 mice [39]. A specific species of
Prevotella, P. copri, is overrepresented in patients with
new-onset RA [14] and was recently shown to increase
colonic Th17 cells and promote arthritis in SKG mice
after co-exposure to the fungal component zymosan
[18]. On the other hand, P. histicola has been reported
to suppress collagen-induced arthritis in transgenic mice
expressing RA-susceptibility gene HLA-DQ8 [40].
Therefore, the immunomodulatory effects of the gut
microbiota, including Prevotella, are species- and some-
times even strain-dependent. Due to inherently limited
resolution of 16S rRNA gene sequencing, our data on
the abundance of Prevotella is limited to the genus level
and the exact Prevotella species altered in IL1rn−/− mice
remain unclear. Overall, it is tempting to speculate that
complex alterations in several taxa determine the net
mucosal response to affect arthritis. It should also be
noted that fecal bacterial community structures do not
fully mirror the site-specific luminal or mucosa-
associated microbiota profiles and were used in this
study as a proxy of the gut microbiota of the Il1rn−/−
mice.
Our previous studies showed that IL1rn−/− Tlr2−/−
mice develop a more severe arthritis compared with
IL1rn−/− mice [12]. Given that additional TLR2 defi-
ciency did not affect the microbiota of IL1rn−/− mice to
a major extent (Fig. 1), we speculate that severe arthritis
in IL1rn−/− Tlr2−/− mice is due to the altered host im-
mune response, specifically reduced function of Treg
cells [12], rather than alteration in the microbiome.
However, the data regarding lack of a major influence of
TLR2 deficiency on Il1rn−/− microbiota should be inter-
preted with caution due to the absence of littermate
Il1rn−/− Tlr2+/+ mice in our studies.
IL1rn−/− mice had specific expansion of intestinal
Th17 cells. The pathogenic relevance of IL-17 in the de-
velopment of arthritis in IL1rn−/− mice has been demon-
strated before, since both IL-17 gene deficiency and
treatment with neutralizing anti-IL-17 antibodies inhibit
arthritis [4, 8]. A previous study showed that γδ T cells
rather than Th17 cells represent most IL-17-producing
T cells in the inflamed joints of IL1rn−/− mice [41].
While γδ17 and Th17 cells may have complementary
pathogenic roles in the development of IL1rn−/− arth-
ritis, our data suggest that IL-17-producing cells located
in lamina propria and induced by IL1rn−/− intestinal
microbiota are TCRβ-expressing CD4+ Th17 cells (Fig. 4
and Additional file 1: Figure S4).
The expansion of LP Th17 cells in IL1rn−/− mice was
caused by the dysregulated microbiota as confirmed by
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fecal transfer experiments (Fig. 3g–i). A critical patho-
genic link to the spontaneous arthritis was revealed by
our germ-free and antibiotic treatment studies (Figs. 4
and 5). Other previous studies which demonstrated the
involvement of the gut microbiota in exacerbation of
autoimmune arthritis found SFB as the responsible mi-
croorganisms. One study showed a role for vancomycin-
sensitive microbiota including SFB in the induction of
IL-17- and autoantibody-driven arthritis in K/BxN mice
[13], and another showed that SFB can lower the activa-
tion threshold of self-reactive T cells and promote the
differentiation of arthritogenic Th1 cells in a T cell trans-
fer model of arthritis [42]. Our data are the first to dem-
onstrate that although SFB colonization exacerbates
arthritis, among the dysregulated indigenous microbiota
present in the IL1rn−/− mice, those sensitive to tobra-
mycin, i.e., Helicobacter, Flexispira, Clostridium and
Dehalobacterium, are potential candidates to promote
arthritis in a genetically susceptible host. This is relevant
for human disease, given that SFB were not found in
genome-wide sequences of 263 gut metagenomes of
human adults [30, 31].
Our data also provide the first evidence for the in-
volvement of TLR4 in defining the intestinal mucosal T
cell phenotype. TLR4 activation of LP mononuclear cells
by IL1rn−/− microbiota-induced IL-1β, IL-23 and IL-6
(Fig. 7a–c). Microbiota-induced IL-1β is critical for the
development of steady-state Th17 cells in the gut [43].
IL-1 also synergizes with IL-6 and IL-23 to regulate early
differentiation of Th17 cells and maintain cytokine ex-
pression in effector Th17 cells [44]. It was recently
shown that infectious triggers such as influenza lung in-
fection and colitis trigger an IL-1β-induced Th17 differ-
entiation and promote arthritis induced by KRN
transgenic T cells [45]. Interestingly, a subset of human
CD14+ CD163low lamina propria cells expressing both
macrophage and DC markers has been found to express
TLR4, produce IL-1β and IL-6 upon TLR4 stimulation,
and induce Th17 differentiation [46]. However, the spe-
cific subset of LP phagocytes that orchestrates the
phase-dependent TLR4-mediated mucosal response to
microbiota in our studies remains to be determined.
Several studies have shown that TLR4 deficiency and
systemic inhibition of TLR4 using specific antagonists or
neutralizing antibodies can suppress experimental arth-
ritis [12, 47–49]. Importantly, TLR4 is believed to be
hyper-responsive in both blood monocyte-derived DCs
and CD14+ synovial fluid macrophages of RA patients
compared with healthy controls [50, 51]. Pathways asso-
ciated with TLR signaling are upregulated in synovial
fluid macrophages of patients with RA. A proinflamma-
tory role for TLR4 during arthritis has previously been
widely attributed to TLR4 activation by endogenous
damage-associated molecular patterns present in the
joint rather than microbial agonists [12, 49, 52, 53]. Our
observations suggest that TLR4-mediated modulation of
the mucosal immune response in intestinal LP may be
another function involving TLR4 in arthritis.
Conclusions
Our study reveals a crucial role for IL-1Ra in regulation
of the diversity and the composition of intestinal micro-
biota and a balanced T cell response in the intestinal LP.
We show that the aberrant microbiota in IL1rn−/− mice
have the capacity to enhance LP Th17 cells which are
associated with arthritis, likely via TLR4-induced pro-
duction of IL-1β, IL-6, and IL-23. Although IL1rn−/− in-
testinal microbiota do not cause arthritis in a normal
(WT) host, these microbiota, in particular tobramycin-
sensitive bacteria, contribute to the development of arth-
ritis in IL1rn−/− mice. Our data suggest that the interplay
between IL-1Ra, intestinal microbiota, TLR4, and muco-
sal T cells may serve as a potential predisposing or initi-
ating event in the context of autoimmune disease and
provide opportunities to control RA.
Methods
Mice
IL1rn−/− mice on a BALB/c background were kindly
provided by Dr. M. Nicklin (Sheffield, UK) [54]. WT
BALB/c mice were purchased from Harlan, UK. Mice
were co-housed in filter-top non-individually ventilated
(non-IVC) cages in the same room in our animal facility
for at least 8 weeks prior to feces collection for pyrose-
quencing. IL1rn−/− Tlr4−/− mice and their IL1rn−/− Tlr+/+
littermates were generated as described before [12] and
used for microbiota sequencing. IL1rn−/− Tlr2−/− mice were
compared to non-littermate IL1rn−/− mice in this study.
Microbiota sequencing and data analysis
Fecal bacterial DNA from 15-week-old mice was isolated
using phenol-, chloroform-, isoamyl alcohol-based ex-
traction (Sigma). Sequencing was performed by DNAVi-
sion (Charleroi, Belgium) on a Roche 454 GS-FLX
System using 16S rRNA gene bar-coded primers target-
ing the V5-V6 conserved DNA regions (forward primer
784F: 5′-AGGATTAGATACCCTGGTA-3′, reverse
primer 1061R: 5′-CRRCACGAGCTGACGAC-3′) [55].
For gene sequence analysis, a customized workflow
based on Quantitative Insights Into Microbial Ecology
(QIIME version 1.2) was adopted (http://qiime.org/) [56].
Settings recommended in QIIME 1.2 tutorial were
applied. Additionally, reads were filtered for chimeric
sequences using Chimera Slayer as described before [57].
OTU clustering was performed with settings as recom-
mended by QIIME [58] using an identity threshold of
97%. The Ribosomal Database Project classifier version
2.2 was used for taxonomic classification [59]. Hierarchical
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clustering of samples was performed using UPGMA with
weighted UniFrac as a distance measure as imple-
mented in QIIME 1.2. For statistical analysis and
generation of figures, a custom QIIME implemented
R-package, SciPy [60] (www.Scipy.org), Graphpad Prism
version 5.0, and Microsoft® Office Excel® 2007 were
adopted. Presence of SFB was assessed by real-time
quantitative PCR (qPCR) on fecal DNA using SFB-specific
primers as described before [61]. The delta Ct (cycle
threshold) value was calculated for SFB-specific rRNA
gene relative to the total (conserved) bacterial 16S rRNA
genes amplified using universal bacterial primers to
correct for the total bacterial DNA input. Data are
presented as delta Ct (ΔCt) and relative SFB expression
calculated as 2−ΔCt × 10,000 (Additional file 1: Table S3).
Microbiota transfer and co-housing
IL1rn−/− microbiota were transferred to WT mice by oral
gavage of 200 μl of a homogenized IL1rn−/− fecal sus-
pension prepared in sterile PBS. Immediately hereafter,
the gavaged WT mice were co-housed with IL1rn−/−
mice in the same individually ventilated cage for a
period of 6 weeks to ensure sustained microbiota trans-
fer by coprophagy. The control WT mice were gavaged
with their own fecal suspension and housed separate
from IL1rn−/− fecal-transplanted mice in IVC cages. To
verify microbiota of conventional IL1rn−/− mice can trig-
ger arthritis, GF IL1rn−/− mice received either 200 μl of
sterile water or 200 μl fecal suspensions of conventional
IL1rn−/− mice and were monitored for the development
of arthritis for 8 weeks. In some studies, IL1rn−/− mice
were co-housed with IL1rn−/−Tlr4−/− mice for 10 days
before analysis of LP T cells.
Antibiotic treatments and reconstitution with SFB
Intestinal microbiota were depleted using a cocktail
of metronidazole (Acros Organics), neomycin trisulfate
(Sigma), and ampicillin sodium salt (Sigma) (all 1 g/l)
provided in drinking water for 1 week. Indicated groups
received 200 μl fecal suspensions of SFB-monocolonized
mice by oral gavage 1 week after ceasing antibiotics. For
single antibiotic treatments, ampicillin sodium salt (1 g/l),
metronidazole (1 g/l), vancomycin hydrochloride (0.5 g/l,
Fisher Scientific), or tobramycin sulfate (1 g/l, Centrafarm)
was added to drinking water for 8 weeks and refreshed
once a week. Sucrose (6 g/l) was added to drinking water
of all groups including controls during treatments.
Isolation of lamina propria cells
Lamina propria mononuclear cells were isolated from
the small intestine and colon after removing mesenteric
fat and Peyer’s patches, followed by incubation with
33 mM EDTA on ice for 30 min to remove epithelial cells,
and subsequent digestion with 1 mg/ml collagenase-D
(Roche) and 10 μg/ml DNAse I (Sigma) at 37 °C for three
cycles of 15 min. LP lymphocytes were then harvested at
the interphase of a 40:80% percoll gradient (Sigma), washed
thoroughly, and used in culture as described below.
Cell cultures and cytokine measurements
SI-LP mononuclear cells (4 × 105 cells/well), LN cells
(2 × 105 cells/well), and splenocytes (1 × 105 cells/well) were
cultured in round-bottom 96-well plates in the presence of
PMA (50 ng/ml; Sigma) and ionomycin (1 μg/ml; Sigma)
for 5 or 6 h, as indicated in the figure legends. SI-LP cells
were also cultured for 24 h in the presence of IL1rn−/− or
IL1rn−/−Tlr4−/− complete microbial antigens (1:200 v/v
ratio) prepared by autoclaving the IL1rn−/− fecal pellets
dissolved in PBS, and then centrifuging the suspension at
2000 rpm for 5 min. Cytokine levels in culture supernatants
were measured by Luminex using the mouse cytokine/
chemokine magnetic bead kit (Milliplex and Bio-Rad).
Flow cytometry
For intracellular cytokine staining, SI-LP cells were incu-
bated with PMA (50 ng/ml; Sigma), ionomycin (1 μg/ml;
Sigma), and Brefeldin A (1 μl/ml; BD Biosciences) at
37 °C for 4 h. Cells were stained with fixable viability dye
Efluor780 (eBioscience), anti-TCRβ-FITC (Biolegend) or
anti-CD3-PE (BD pharmigen), and anti-CD4-APC
(Biolegend), then fixed and permeabilized using fixation/
permeabilization buffer (eBioscience), and stained with
anti-IL-17-FITC (Biolegend), IL-17-PECy7 (Biolegend), or
anti-IFNγ-FITC (BD pharmingen) in permeabilization
buffer (eBioscience).
Assessment of arthritis
Severity of arthritis was scored using a previously stan-
dardized arbitrary scoring system on a 0–2 scale per paw
[12]. Arthritis developed only in ankle joints (maximum
score of 4). For histology, total ankle joints were isolated
and fixed in 4% formaldehyde for 4 days, thereafter
decalcified in 5% formic acid and embedded in paraffin.
Tissue sections of 7 μm were stained using hematoxylin
and eosin to study synovial inflammation, cartilage de-
struction, and bone erosion. Each parameter was scored
on a scale from 0 to 3 in a blinded manner.
Statistics
Group measures are expressed as mean + SEM. Statis-
tical significance was tested using an unpaired two-tailed
Mann-Whitney U test to compare two and ANOVA to
compare more groups, with Bonferroni correction for
multiple testing when applicable (GraphPad Prism 5.0).
Arthritis scores were compared using repeated measures
ANOVA with Bonferroni correction. Significance is indi-
cated on figures as follows: n.s. (not significant), *P <
0.05, **P < 0.01, ***P < 0.001.
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